Moolec Science (Moolec Science) Debt-to-Revenue : 8.27 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Moolec Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.39 Mil. Moolec Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.95 Mil. Moolec Science's annualized Revenue for the quarter that ended in Dec. 2023 was $1.01 Mil. Moolec Science's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 8.27.

Moolec Science Debt-to-Revenue Historical Data

The historical data trend for Moolec Science's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science Debt-to-Revenue Chart

Moolec Science Annual Data

Trend

Jun21

Jun22

Jun23

Debt-to-Revenue

N/A

2.92

Moolec Science Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial					N/A	N/A	0.73	0.40	8.27

Competitive Comparison of Moolec Science's Debt-to-Revenue

For the Biotechnology subindustry, Moolec Science's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Moolec Science's Debt-to-Revenue falls into.

Moolec Science Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Moolec Science's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.546	+	0.099)	/	0.905
	=	2.92

Moolec Science's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.39	+	5.945)	/	1.008
	=	8.27

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

Moolec Science Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Moolec Science's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Moolec Science (Moolec Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411

Website

https://www.moolecscience.com

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.